Reinhard Kandera

Insider Reports History

Location
New York, NY
Signature
/s/ Reinhard Kandera
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Reinhard Kandera:

Form 4 holding Chief Financial Officer, Director

HOOKIPA Pharma Inc.

Security class
Common Stock
Shares / value
43,092
Estimated value
$31,242
Report date
21 Aug 2023
Price
$0.7250
Ownership
Direct
Form 4 holding Chief Financial Officer, Director

HOOKIPA Pharma Inc.

Security class
Stock Option (Right to Buy)
Shares / value
406,200
Estimated value
Report date
15 Apr 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Reinhard Kandera

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .